{"id":"W3019696896","doi":"10.1093/rheumatology/keaa111.241","title":"P248 Subcutaneous secukinumab 150 mg provides rapid and sustained relief in total and nocturnal back pain, morning stiffness and fatigue in patients with active AS over 4 years","year":2020,"lang":"en","type":"article","venue":"Lara D. Veeken","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Oakville-Trafalgar Memorial Hospital","funders":"","keywords":"Medicine; Secukinumab; Placebo; BASDAI; Ankylosing spondylitis; Morning; Physical therapy; Minimal clinically important difference; Population; Low back pain; Back pain; Randomized controlled trial; Internal medicine; Arthritis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000256096,0.000417775,0.0009460628,0.0001392141,0.0001179582,0.0003001934,0.0002153743,0.0002799381,0.00267893],"category_scores_gemma":[0.0004805228,0.000156758,0.0004813039,0.0001038477,0.00015876,0.0002572813,0.0001152476,0.000553669,0.0004668447],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001121968,"about_ca_system_score_gemma":0.0001468257,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002915407,"about_ca_topic_score_gemma":0.0005812176,"domain_scores_codex":[0.9998647,0.00004610089,0.00001281358,0.00001873683,0.00002097572,0.00003656465],"domain_scores_gemma":[0.9998148,0.00004142913,0.00005031158,0.00001591102,0.0000128439,0.00006465935],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3639957,0.02586158,0.020923,0.0009554279,0.001118607,0.0009955587,0.0004027966,0.001769826,0.2503036,0.0001100008,0.00366608,0.3298978],"study_design_scores_gemma":[0.06945413,0.6795178,0.2264363,0.00008852665,0.0006170995,0.001132648,0.0002971167,0.0027213,0.01685937,0.00009437751,0.0027296,0.00005173354],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.998919,0.0004637498,0.00007128773,0.00004503476,0.0000216911,0.0000445168,0.00007756134,0.00003362019,0.0003235781],"genre_scores_gemma":[0.9989324,0.0002099019,0.0001167586,0.00006293317,0.00003293498,0.00005226486,0.0001153083,0.000003295509,0.0004741151],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00267893,"threshold_uncertainty_score":0.008961916,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008281182553848783,"score_gpt":0.2250775317982402,"score_spread":0.2167963492443914,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}